Loading...

Regeneron Pharmaceuticals, Inc.

REGN•NASDAQ
Healthcare
Biotechnology
$751.57
$-14.45(-1.89%)
U.S. Market opens in 49h 27m

Regeneron Pharmaceuticals, Inc. (REGN) Stock Overview

Explore Regeneron Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap78B
P/E Ratio17.09
EPS (TTM)$41.48
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$729.60
3 Months$362.06
1 Year Target$875.98

REGN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Regeneron Pharmaceuticals, Inc. (REGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.76, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $875.98.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 17.09 and a market capitalization of 78B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.89%
5-Day Change
-0.42%
1-Month Change
1.33%
3-Month Change
-0.26%
6-Month Change
30.04%
Year-to-Date (YTD) Change
-2.63%
1-Year Change
25.31%
3-Year Change
-5.70%
5-Year Change
49.96%
All-Time (Max) Change
3456.89%

Contact Information

https://www.regeneron.com
914 847 7000
777 Old Saw Mill River Road, Tarrytown, NY, 10591-6707

Company Facts

15,158 Employees
IPO DateApr 2, 1991
CountryUS
Actively Trading

Frequently Asked Questions